1型糖尿病30年随访中胰岛素剂量与心血管代谢风险及心血管疾病的关系
基于DCCT/EDIC研究30年随访数据,分析1441例1型糖尿病患者胰岛素剂量与心血管代谢风险因素及心血管疾病结局的关系。结果显示较高胰岛素剂量与更差的心血管代谢风险谱(BMI、脉率、甘油三酯升高,HDL降低)显著相关,但校正其他心血管风险因素后与心血管疾病风险无显著关联。
要点
- 较高胰岛素剂量与更差的心血管代谢风险因素谱相关
- 校正其他风险因素后胰岛素剂量与心血管疾病风险无显著关联
- 胰岛素剂量增加与心血管疾病风险的关联可能由其他风险因素介导
核心结论
- DCCT/EDIC研究中,较高胰岛素剂量与多项心血管代谢风险因素的不良趋势相关,即使多变量校正后仍存在。
- 但胰岛素剂量与心血管疾病事件风险无显著关联。
研究设计与样本
- DCCT/EDIC研究,1441例1型糖尿病患者随机分配至强化或常规治疗,DCCT平均随访6.5年后96%存活者进入EDIC观察性研究,每年随访,总随访30年。
- 使用广义线性混合模型和Cox比例风险回归模型分别评估胰岛素剂量与心血管代谢风险因素及心血管疾病风险的关联。
主要发现
- 较高胰岛素剂量与更差的心血管代谢风险谱显著相关:BMI、脉率、甘油三酯更高,HDL胆固醇更低;但舒张压和LDL胆固醇更低。
- 最小校正模型中,胰岛素剂量每增加0.1单位/kg体重/天,任何心血管疾病风险增加6%(95% CI 3, 9)。
- 校正其他心血管风险因素后,胰岛素剂量与心血管疾病的关联不再显著。
临床怎么用
- 临床中较高胰岛素剂量提示需关注心血管代谢风险因素(BMI、脉率、甘油三酯、HDL等)的监测与管理。
- 胰岛素剂量本身不直接增加心血管疾病风险,但可能通过影响其他风险因素间接相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study demonstrated the beneficial effects of intensive therapy on atherosclerosis and clinical cardiovascular disease (CVD) outcomes. The current analyses evaluated the relationship between longitudinal changes in insulin dose and CVD risk factors and outcomes. RESEARCH DESIGN AND METHODS: A total of 1,441 participants were randomly assigned to intensive or conventional diabetes therapy during the DCCT. After an average of 6.5 years of follow-up, 96% of the surviving cohort enrolled in the EDIC observational study, which included annual visits with detailed medical history, physical examination, and laboratory testing. CVD events were adjudicated by a review committee. Generalized linear mixed models and Cox proportional hazards regression models were used to assess the association between insulin dose and cardiometabolic risk factors and CVD risk, respectively, over a total of 30 years. RESULTS: Higher insulin doses were significantly associated with a less favorable cardiometabolic risk profile (higher BMI, pulse rate, and triglycerides and lower HDL cholesterol) with the exception of lower diastolic blood pressure and lower LDL cholesterol. In a minimally adjusted model, a 0.1 unit/kg body wt/day increase in insulin dose was associated with a 6% increased risk of any CVD (95% CI 3, 9). However, the association with insulin dose was no longer significant after adjustment for other CVD risk factors. CONCLUSIONS: During DCCT/EDIC, higher insulin doses were associated with adverse trends in several cardiometabolic risk factors, even after multivariable adjustment, but not with incident CVD outcomes.
引用
- Braffett BH, Dagogo-Jack S, Bebu I, et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care. 2019. PMID: 30728218. doi:10.2337/dc18-1574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。